Mainz Biomed Management
Management criteria checks 1/4
Mainz Biomed's CEO is Guido Baechler, appointed in Jul 2021, has a tenure of 3.42 years. directly owns 2.94% of the company’s shares, worth €87.11K. The average tenure of the management team and the board of directors is 1.9 years and 3 years respectively.
Key information
Guido Baechler
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.4yrs |
| CEO ownership | 2.9% |
| Management average tenure | 1.9yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO
Guido Baechler (59 yo)
3.4yrs
Tenure
Mr. Guido Baechler serves as Chief Executive Officer at Mainz Biomed N.V. since July 1, 2021 and has been its Executive Director since July 2021. Mr. Baechler served as Chief Executive Officer at SummerBio...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.4yrs | no data | 2.94% € 87.1k | |
| Chief Financial Officer | 3.4yrs | no data | 0.83% € 24.6k | |
| Chief Operating Officer | 1.9yrs | no data | 0.026% € 782.6 | |
| Chief Technology Officer | 1.9yrs | no data | 0.046% € 1.4k | |
| Chief Science Officer & Executive Director | 3.3yrs | no data | 4.4% € 130.4k | |
| Head of Human Resources | 1.9yrs | no data | no data | |
| Chief Business Officer | 1.9yrs | no data | 1.41% € 41.9k |
1.9yrs
Average Tenure
54.5yo
Average Age
Experienced Management: 4TO's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.4yrs | no data | 2.94% € 87.1k | |
| Chief Science Officer & Executive Director | 16.5yrs | no data | 4.4% € 130.4k | |
| Independent Non-Executive Director | 3.1yrs | no data | 2.8% € 83.0k | |
| Independent Non-Executive Director | 2yrs | no data | 0.14% € 4.1k | |
| Independent Non-Executive Chairman | 2yrs | no data | 0.34% € 10.2k | |
| Member of Strategic Advisory Board | 3.1yrs | no data | no data | |
| Member of Strategic Advisory Board | 2.9yrs | no data | no data | |
| Member of Strategic Advisory Board | 2.8yrs | no data | no data | |
| Member of Strategic Advisory Board | no data | no data | no data |
3.0yrs
Average Tenure
59yo
Average Age
Experienced Board: 4TO's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 07:48 |
| End of Day Share Price | 2024/12/05 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mainz Biomed N.V. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yi Chen | H.C. Wainwright & Co. |